Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.37 | 1.42 |
NAV | ₹505.67 | ₹108.32 |
Fund Started | 20 Jul 2000 | 08 Apr 2008 |
Fund Size | ₹97460.90 Cr | ₹68033.76 Cr |
Exit Load | Exit Load for units in excess of 15% of the investment,1% will be charged for redemption within 1 year. | Exit load of 1% if redeemed upto 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 9.91% | 12.93% |
3 Year | 22.48% | 21.70% |
5 Year | 26.84% | 25.85% |
1 Year
3 Year
5 Year
Equity | 60.38% | 92.49% |
Cash | 11.59% | 5.91% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 5.51% |
ICICI Bank Ltd. | 4.06% |
Reliance Industries Ltd. | 3.56% |
Infosys Ltd. | 3.10% |
State Bank of India | 2.83% |
Bharti Airtel Ltd. | 2.77% |
NTPC Ltd. | 2.56% |
Axis Bank Ltd. | 2.41% |
Larsen & Toubro Ltd. | 2.28% |
Coal India Ltd. | 2.21% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.81% |
ICICI Bank Ltd. | 8.97% |
Reliance Industries Ltd. | 6.48% |
Larsen & Toubro Ltd. | 5.83% |
Bharti Airtel Ltd. | 4.47% |
Maruti Suzuki India Ltd. | 4.25% |
Axis Bank Ltd. | 4.23% |
Ultratech Cement Ltd. | 4.10% |
Infosys Ltd. | 3.34% |
Sun Pharmaceutical Industries Ltd. | 2.91% |
Name | Anil Bamboli | Vaibhav Dusad |
Start Date | 16 Apr 2021 | 02 May 2020 |
Name
Start Date
Description | The Scheme seeks to provide long term capital appreciation / income from a dynamic mix of equity and debt investments. | The scheme seeks to generate long term capital appreciation and income distribution to investors from a portfolio that is predominantly invested in equity and equity related securities of large cap companies. |
Launch Date | 20 Jul 2000 | 08 Apr 2008 |
Description
Launch Date